Polyostotic Fibrous Dysplasia
📧 Sign up to get email alerts when something new happens for Polyostotic Fibrous Dysplasia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Alendronate to Treat Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome [Phase 2]
A Phase 2 clinical trial update reports on using alendronate to treat polyostotic fibrous dysplasia and McCune-Albright syndrome, with the s…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Effects of Letrozole on Precocious Puberty Due to McCune Albright Syndrome [Phase 1]
Phase 1 trial evaluating the effects of letrozole on precocious puberty associated with McCune-Albright syndrome has completed. The sponsor …
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Studies on Abnormal Bone From Patients With Polyostotic Fibrous Dysplasia and McCune Albright Syndrome
This item notes a completed clinical trial sponsored by the National Institute of Dental and Craniofacial Research investigating abnormal bo…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Testolactone for the Treatment of Girls With LHRH Resistant Precocious Puberty [Phase 2]
A Phase 2 clinical trial evaluating testolactone for LHRH-resistant precocious puberty in girls has completed, with consideration of cases a…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome [Phase 3]
A Phase 3 trial evaluating pegvisomant for growth hormone excess in McCune-Albright syndrome has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.